Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy

Rujiao Liu(Fudan University Shanghai Cancer Center), Xiaodong Zhu(Fudan University Shanghai Cancer Center), Li‐Xin Qiu(Fudan University Shanghai Cancer Center), Xin Liu(Xi'an Jiaotong University), Jin Li(Hainan Medical University), Weijian Guo, Jiliang Yin(Shanghai Medical College of Fudan University), Xiaoying Zhao(Handan College), Guang He(Shanghai Jiao Tong University), Zhiyu Chen(Chongqing University), Ruixuan Geng(Shanghai Medical College of Fudan University)
Tumor Biology
August 27, 2015
10.1007/s13277-015-3935-8
Cited by 13

Related Papers

CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress–induced myocardial necroptosis
|Nature Medicine|2016|791
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Non-invasive early detection of cancer four years before conventional diagnosis using a blood test
|Nature Communications|2020|641
Genetic evidence supports demic diffusion of Han culture
|Nature|2004|482
Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes
|Nature Genetics|2018|476